|
MorphoSys AG
MOR
|
$ 18.96 |
2.43 % |
$ 254 M |
Nasdaq Global Select Market |
Germany |
|
Sorrento Therapeutics
SRNE
|
$ 0.27 |
-29.58 % |
$ 126 M |
Nasdaq Global Select Market |
USA |
|
BioCryst Pharmaceuticals
BCRX
|
$ 7.57 |
- |
$ 1.45 B |
Nasdaq Global Select Market |
USA |
|
Corbus Pharmaceuticals Holdings
CRBP
|
$ 10.41 |
-5.36 % |
$ 43.9 M |
Nasdaq Global Market |
USA |
|
Cerus Corporation
CERS
|
$ 1.58 |
- |
$ 285 M |
Nasdaq Global Market |
USA |
|
Cellectis S.A.
CLLS
|
$ 1.64 |
3.14 % |
$ 116 M |
Nasdaq Global Market |
France |
|
ContraFect Corporation
CFRX
|
$ 1.47 |
-5.16 % |
$ 5.39 M |
Nasdaq Capital Market |
USA |
|
Orchard Therapeutics plc
ORTX
|
$ 4.93 |
1.02 % |
$ 90.8 M |
Nasdaq Global Select Market |
Britain |
|
Advaxis
ADXS
|
$ 0.31 |
-9.65 % |
$ 45.9 M |
Nasdaq Capital Market |
USA |
|
Heat Biologics, Inc.
HTBX
|
$ 3.93 |
-5.76 % |
$ 99.8 M |
Nasdaq Capital Market |
USA |
|
La Jolla Pharmaceutical Company
LJPC
|
$ 6.2 |
- |
$ 154 M |
Nasdaq Capital Market |
USA |
|
Zymeworks
ZYME
|
$ 6.42 |
- |
$ 404 M |
NYSE |
Canada |
|
Checkmate Pharmaceuticals
CMPI
|
$ 10.5 |
- |
$ 231 M |
Nasdaq Global Market |
USA |
|
Kadmon Holdings, Inc.
KDMN
|
$ 9.5 |
- |
$ 1.7 B |
Nasdaq Global Select Market |
USA |
|
Dyadic International
DYAI
|
$ 1.75 |
- |
$ 50.4 M |
Nasdaq Capital Market |
USA |
|
BioDelivery Sciences International
BDSI
|
$ 2.58 |
-4.8 % |
$ 255 M |
Nasdaq Global Select Market |
USA |
|
Zosano Pharma Corporation
ZSAN
|
$ 0.56 |
7.23 % |
$ 2.72 M |
Nasdaq Global Select Market |
USA |
|
Ayala Pharmaceuticals
AYLA
|
$ 0.5 |
- |
$ 7.46 M |
Nasdaq Global Market |
Israel |
|
Evogene Ltd.
EVGN
|
$ 1.35 |
- |
$ 27.9 M |
Nasdaq Global Market |
Israel |
|
Acceleron Pharma Inc.
XLRN
|
$ 179.68 |
- |
$ 10.9 B |
Nasdaq Global Market,SPB |
USA |